1. Mjones H. Paralysis agitans. A clinical genetic study. Acta Psychiatr Neurol Scand 1949; 25(suppl 54):1-195.
2. Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 1995; 22(4):272-279.
3. Golbe LI, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996; 40(5):767-775.
4. Wszolek ZK, Pfeiffer B, Fulgham JR, et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995; 45(3 Pt 1):502-505.
5. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 1996; 47(1):155-160.
6. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994; 36(4):659-661.
7. Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 2003; 54(4):507-513.
8. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392(6676):605-608.
9. Valente EM, Brancati F, Ferraris A, et al. PARK6-linked parkinsonism occurs in several European families. Ann Neurol 2002; 51(1):14-18.
10. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299(5604):256-259.
11. Koller W, O'Hara R, Nutt J, Young J, Rubino F. Monozygotic twins with Parkinson's disease. Ann Neurol 1986; 19(4):402-405.
12. Pahwa R, Busenbark K, Gray C, Koller WC. Identical twins with similar onset of Parkinson's disease: a case report. Neurology 1993; 43(6):1159-1161.
13. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33(7):815-824.
14. Vieregge P, Schiffke KA, Friedrich HJ, Muller B, Ludin HP. Parkinson's disease in twins. Neurology 1992; 42(8):1453-1461.
15. Marttila RJ, Kaprio J, Koskenvuo M, Rinne UK. Parkinson's disease in a nationwide twin cohort. Neurology 1988; 38(8):1217-1219.
16. Wirdefeldt K, Gatz M, Schalling M, Pedersen NL. No evidence for heritability of Parkinson disease in Swedish twins. Neurology 2004; 63(2):305-311.
17. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. J Am Med Assoc 1999; 281(4):341-346.
18. Sveinbjornsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 2000; 343(24):1765-1770.
19. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002; 52(5):549-555.
20. Racette BA, Good L, Kissel AM, Criswell SR, Perlmutter J.S. A population based study of parkinsonism in an Amish community. Neurology 2006; 66:S53.005.
21. Svenson LW, Platt GH, Woodhead SE. Geographic variations in the prevalence rates of Parkinson's disease in Alberta. Can J Neurol Sci 1993; 20(4):307-311.
22. Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology 1990; 40(8):1218-1221.
23. Hubble JP, Cao T, Hassanein RE, Neuberger JS, Koller WC. Risk factors for Parkinson's disease. Neurology 1993; 43(9):1693-1697.
24. Granieri E, Carreras M, Casetta I, et al. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol 1991; 48(8):854-857.
25. Zayed J, Ducic S, Campanella G, et al. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1990; 17(3):286-291.
26. Schoenberg BS, Osuntokun BO, Adeuja AO, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988; 38(4):645-646.
27. Taba P, Asser T. Prevalence of Parkinson's disease in Estonia. Acta Neurol Scand 2002; 106(5):276-281.
28. Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 1993; 8(1):87-92.
29. Aquilonius SM, Hartvig P. A Swedish county with unexpectedly high utilization of antiparkinsonian drugs. Acta Neurol Scand 1986; 74(5):379-382.
30. Lux WE, Kurtzke JF. Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology 1987; 37(3):467-471.
31. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 1984; 16(3):278-282.
32. Sutcliffe RL, Meara JR. Parkinson's disease epidemiology in the Northampton District, England, 1992. Acta Neurol Scand 1995; 92(6):443-450.
33. Peters HA, Levine RL, Matthews CG, Chapman LJ. Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 1988; 45(5):537-540.
34. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning: Clinical pictures and manganese turnover. Neurology 1967; 17:128-136.
35. Rodier J. Manganese poisoning in Moroccan miners. Brit J Industr Med 1955; 12:21-35.
36. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219(4587):979-980.
37. Sechi GP, Agnetti V, Piredda M, et al. Acute and persistent parkinsonism after use of diquat. Neurology 1992; 42(1):261-263.
38. Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35(5):616-619.
39. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000; 342(21):1560-1567.
40. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Brit Ann Med Pharmacol 1837; 1:41-42.
41. Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 1969; 19(5):674-684.
43. Roels H, Lauwerys R, Buchet JP, et al. Epidemiological survey among workers exposed to manganese: effects on lung, CNS, and some biological indices. Am J Ind Med 1987; 11(3):307-327.
44. Wennberg A, Iregren A, Struwe G, Cizinsky G, Hagman M, Johansson L. Manganese exposure in steel smelters a health hazard to the nervous system. Scand J Work Environ Health 1991; 17(4):255-262.
45. Wennberg A, Hagman M, Johansson L. Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure. Neurotoxicology 1992; 13(1):271-274.
46. Iregren A. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol Teratol 1990; 12(6):673-675.
47. Mergler D, Huel G, Bowler R, et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 1994; 64(2):151-180.
48. Mergler D, Baldwin M, Belanger S, et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology 1999; 20(2-3): 327-342.
49. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48(3):650-658.
50. Gorell JM, Rybicki BA, Cole JC, Peterson EL. Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 1999; 18(6):303-308.
51. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996; 46(5):1275-1284.
52. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993; 43(6):1173-1180.
53. Bocchetta A, Corsini GU. Parkinson's disease and pesticides. Lancet 1986; 2(8516):1163.
54. Sanchez-Ramos JR, Hefti F, Weiner WJ. Paraquat and Parkinson's disease. Neurology 1987; 37(4):728.
55. Barbosa ER, Leiros dC, Bacheschi LA, Scaff M, Leite CC. Parkinsonism after glycine-derivate exposure. Mov Disord 2001; 16(3):565-568.
56. Ferraz HB, Bertolucci PH, Pereira JS, Lima JG, Andrade LA. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988; 38(4):550-553.
57. Golbe LI, Farrell TM, Davis PH. Follow-up study of early-life protective and risk factors in Parkinson's disease. Mov Disord 1990; 5(1):66-70.
58. Behari M, Srivastava AK, Das RR, Pandey RM. Risk factors of Parkinson's disease in Indian patients. J Neurol Sci 2001; 190(1-2):49-55.
59. Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H. Pesticides and risk of Parkinson disease: a population-based case-control study. Arch Neurol 2005; 62(1):91-95.
60. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50(5):1346-1350.
61. Melamed E, Lavy S. Parkinsonism associated with chronic inhalation of carbon tetrachloride. Lancet 1977; 1(8019):1015.
62. Pezzoli G, Antonini A, Barbieri S, et al. n-Hexane-induced parkinsonism: pathogenetic hypotheses. Mov Disord 1995; 10(3):279-282.
63. Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology 1994; 44(6):1051-1054.
64. Pezzoli G, Canesi M, Antonini A, et al. Hydrocarbon exposure and Parkinson's disease. Neurology 2000; 55(5):667-673.
65. Fall PA, Fredrikson M, Axelson O, Granerus AK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999; 14(1):28-37.
66. Tanner CM, Chen B, Wang W, et al. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989; 39(5):660-664.
67. Hertzman C, Wiens M, Bowering D, Snow B, Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 1990; 17(3):349-355.
68. Tsui JK, Calne DB, Wang Y, Schulzer M, Marion SA. Occupational risk factors in Parkinson's disease. Can J Public Health 1999; 90(5):334-337.
69. Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 1998; 19(4-5):709-712.
70. Noonan CW, Reif JS, Yost M, Touchstone J. Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. Scand J Work Environ Health 2002; 28(1):42-48.
71. Savitz DA, Loomis DP, Tse CK. Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 1998; 53(1):71-74.
72. Wang WZ, Fang XH, Cheng XM, Jiang DH, Lin ZJ. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology 1993; 12(4):209-218.
73. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50(5):1346-1350.
74. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997; 48(6):1583-1588.
75. Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R. Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy. Acta Neurol Scand 2002; 105(2):77-82.
76. Semchuk KM, Love EJ, Lee RG. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992; 42(7):1328-1335.
77. Rocca WA, Anderson DW, Meneghini F, et al. Occupation, education, and Parkinson's disease: a case-control study in an Italian population. Mov Disord 1996; 11(2):201-206.
78. Petrovitch H, Ross GW, Abbott RD, et al. Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol 2002; 59(11):1787-1792.
79. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974; 30(1): 59-64.
80. Whitlock CM, Jr., Amuso SJ, Bittenbender JB. Chronic neurological disease in two manganese steel workers. Am Ind Hyg Assoc J 1966; 27(5):454-459.
81. Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferro-manganese smelter. Br J Ind Med 1989; 46(12):856-859.
82. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993; 43(8):1479-1483.
83. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993; 50(6):510-513.
84. Sjogren B, Iregren A, Frech W, et al. Effects on the nervous system among welders exposed to aluminium and manganese. Occup Environ Med 1996; 53(1):32-40.
85. Chandra SV, Shukla GS, Srivastava RS, Singh H, Gupta VP. An exploratory study of manganese exposure to welders. Clin Toxicol 1981; 18(4):407-416.
86. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001; 56(1):8-13.
87. Koller WC, Lyons KE, Truly W. Effect of levodopa treatment for parkinsonism in welders: A double-blind study. Neurology 2004; 62(5):730-733.
88. Josephs KA, Ahlskog JE, Klos KJ, et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005; 64(12):2033-2039.
89. Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Occupation and parkinsonism in three movement disorders clinics. Neurology 2005; 65(9): 1430-1435.
90. Wechsler LS, Checkoway H, Franklin GM, Costa LG. A pilot study of occupational and environmental risk factors for Parkinson's disease. Neurotoxicology 1991; 12(3):387-392.
91. Tanner C, Goldman SM, Quinlan P, et al. Occupation and risk of Parkinson's disease (PD): a preliminary investigation of Standard Occupational Codes (SOC) in twins discordant for disease [abstr]. Neurology 2003; 60(suppl 1):A415.
92. Schulte PA, Burnett CA, Boeniger MF, Johnson J. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health 1996; 86(9):1281-1288.
93. Kirkey KL, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Gorell JM. Occupational categories at risk for Parkinson's disease. Am J Ind Med 2001; 39(6):564-571.
94. Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 1994; 9(1):69-75.
95. Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 2005; 64(2):230-235.
96. Park RM, Schulte PA, Bowman JD, et al. Potential occupational risks for neurodegener-ative diseases. Am J Ind Med 2005; 48(1):63-77.
97. Fryzek JP, Hansen J, Cohen S, et al. A cohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders. J Occup Environ Med 2005; 47(5):466-472.
98. Fored CM, Fryzek JP, Brandt L, et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med 2006; 63(2):135-140.
99. Kieburtz K, Kurlan R. Welding and Parkinson disease: is there a bond? Neurology 2005; 64(12):2001-2003.
100. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 2005; 64(12):2021-2028.
101. De Michele G, Filla A, Volpe G, et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 1996; 11(1):17-23.
102. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997; 48(6):1583-1588.
103. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998; 352(9137):1344-1346.
104. Duzcan F, Zencir M, Özdemir F, et al. Familial influence on parkinsonism in a rural area of Turkey (Kizilcaboluk-Denizli): a community-based case-control study. Mov Disord 2003; 18(7):799-804.
Was this article helpful?